<DOC>
	<DOCNO>NCT00386867</DOCNO>
	<brief_summary>This open-label , randomize study compare efficacy , safety , acceptability mifepristone 200 mg follow 24-36 hour either buccal ( i.e. , cheek ) oral misoprostol 800 mcg termination pregnancy woman 63 day L.M.P .</brief_summary>
	<brief_title>A Randomized Trial Buccal Compared Oral Misoprostol Following Mifepristone Medical Abortion 63 Days LMP</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>willing able sign consent form ; eligible medical abortion accord clinician â€™ assessment ; willing undergo surgical completion necessary ; ready easy access telephone emergency transportation ; speak English , Spanish , translator available translate study procedure ; , agree comply study procedure visit schedule . Confirmed suspect ectopic pregnancy undiagnosed adnexal mass ; IUD place ; Chronic renal failure ; Concurrent longterm corticosteroid therapy ; History allergy mifepristone , misoprostol prostaglandin ; Hemorrhagic disorder concurrent anticoagulant therapy ; Inherited porphyria ; Other serious physical mental health condition .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>medical abortion</keyword>
	<keyword>mifepristone</keyword>
	<keyword>misoprostol</keyword>
	<keyword>buccal administration</keyword>
</DOC>